Stock listing

NASDAQ:ONCO Onconetix, Inc. Stock

Home listing (NASDAQ) of Onconetix, Inc.

Follow Onconetix, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:ONCO

$2.89 USD -0.26 (-8.3%)

Close on Nov 20, 2026

Past year -97.5% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$2.85 – $3.31 USDNov 20, 2026
Volume
42,902 sharesNov 20, 2026
Market cap
$2.37M USDAt the close on Nov 20, 2026 · price × 820,611 shares outstanding
52-week range
$0.342 – $161.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$484,109 USDMedian day 60,690 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Onconetix, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ONCO · Home$2.89 USD-0.26 (-8.3%)42,902$3.31$3.31$2.85$3.15Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ONCO · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.89-0.26-8.3%$3.31$3.31$2.8542,902
$3.15+0.15+5.0%$3.12$3.22$3.0463,759
$3.00+0.09+3.1%$2.96$3.01$2.85430,255
$2.91-0.30-9.3%$3.21$3.21$2.7662,029
$3.21+0.18+5.9%$3.09$3.35$2.9170,294
$3.03-0.73-19.4%$3.58$3.58$2.9490,432
$3.76+0.29+8.4%$3.49$3.80$3.4573,100
$3.47-0.11-3.1%$3.38$3.79$3.15217,400
$3.58-3.37-48.5%$7.10$7.10$3.34740,800
$6.95+1.46+26.6%$5.68$7.82$5.618763,000
$5.49-1.09-16.6%$6.35$6.40$5.45110,620
$6.58+0.89+15.6%$5.51$6.69$5.51108,480
$5.69+0.26+4.8%$5.43$5.70$5.1563,850
$5.43+4.869+867.9%$5.38$5.63$5.0166,010
$0.561-0.025-4.3%$0.543$0.585$0.521119,000
$0.586-0.012-2.0%$0.623$0.647$0.551691,100
$0.598+0.123+25.9%$0.508$0.678$0.4814,522,470
$0.475+0.076+19.0%$0.35$0.481$0.342251,550
$0.399-0.019-4.5%$0.41$0.431$0.39382,990
$0.418+0.011+2.7%$0.427$0.43$0.4056,580
$0.407-0.028-6.4%$0.455$0.455$0.4055,470
$0.435+0.029+7.1%$0.43$0.463$0.41268,920
$0.406-0.024-5.6%$0.429$0.429$0.3832,730
$0.43-0.049-10.2%$0.483$0.496$0.42236,590
$0.479-0.069-12.6%$0.522$0.53$0.46363,740
$0.5480.000.0%$0.54$0.554$0.53315,990
$0.548-0.007-1.3%$0.557$0.582$0.5424,970
$0.555-0.035-5.9%$0.552$0.58$0.53532,520
$0.59-0.03-4.8%$0.591$0.601$0.5678,950
$0.62-0.034-5.2%$0.642$0.645$0.601106,910
$0.654+0.057+9.5%$0.62$0.857$0.604,689,860
$0.597-0.064-9.7%$0.66$0.66$0.5860,690
$0.661-0.012-1.8%$0.674$0.686$0.62352,000
$0.673-0.061-8.3%$0.72$0.73$0.6750,330
$0.734-0.01-1.3%$0.738$0.75$0.71340,940
$0.744-0.038-4.9%$0.78$0.78$0.70488,170
$0.782-0.038-4.6%$0.758$0.87$0.7590,520
$0.82-0.29-26.1%$1.05$1.07$0.72547,260
$1.11+0.08+7.8%$1.19$1.36$1.052,256,990
$1.03+0.119+13.1%$1.12$1.42$1.004,778,540
$0.911+0.001+0.1%$0.83$0.92$0.78579,460
$0.91+0.227+33.2%$0.655$1.15$0.6553,196,410
$0.683+0.028+4.3%$0.644$0.70$0.64416,540
$0.655+0.016+2.5%$0.643$0.669$0.63413,390
$0.639-0.025-3.8%$0.67$0.68$0.63917,130
$0.664+0.001+0.2%$0.66$0.674$0.6510,250
$0.663+0.018+2.8%$0.639$0.69$0.63912,280
$0.645+0.008+1.3%$0.649$0.678$0.58661,240
$0.637-0.119-15.7%$0.764$0.778$0.63755,360
$0.756-0.026-3.3%$0.79$0.79$0.74416,550
$0.782-0.031-3.8%$0.819$0.844$0.76717,290
$0.813-0.027-3.2%$0.835$0.835$0.80126,290
$0.84-0.18-17.6%$0.861$0.95$0.82126,200
$1.02+0.281+38.0%$0.739$1.05$0.711666,330
$0.739+0.065+9.6%$0.682$0.745$0.6628,830
$0.674+0.021+3.2%$0.62$0.703$0.629,810
$0.653+0.026+4.1%$0.619$0.69$0.61912,670
$0.627+0.015+2.5%$0.60$0.64$0.58715,360
$0.612-0.02-3.2%$0.628$0.644$0.618,770
$0.632-0.009-1.4%$0.65$0.65$0.6329,540
$0.641-0.002-0.3%$0.645$0.656$0.647,720
$0.643-0.013-2.0%$0.64$0.66$0.6410,480
$0.656+0.005+0.8%$0.65$0.657$0.63335,330
$0.651-0.016-2.4%$0.651$0.666$0.62122,320
$0.667-0.044-6.2%$0.69$0.71$0.6623,120

Splits

4 splits since 2024 · NASDAQ:ONCO · every price before a split is adjusted for it

DayRatioWhat
1-for-10Consolidation
1-for-5Consolidation
1-for-85Consolidation
1-for-40Consolidation
Ticker
NASDAQ:ONCO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Onconetix Announces Reverse Stock Split

Oct 26, 2026

Closed $0.475 (+19.0%) on Oct 27, 2026

All Onconetix, Inc. news

Onconetix, Inc. on 6ix

News releases
23 in the last 12 months · 93 in all · newest Oct 27, 2026 · oldest 2022

Where Onconetix, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:ONCO · Home listing · This pageNASDAQUnited StatesUSD
BOATS:ONCOBOATSUnited StatesUSD
Stuttgart:J4T0StuttgartGermanyEUR
gettex:A426MUgettexGermanyEUR
Frankfurt:J4TFrankfurtGermanyEUR

Valuation

Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$370,091 USD
P/E
Loss
EV/sales
−0.8×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
73.8%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
0.80

Team and board

Officers

OfficerRole
David Allan WhiteChief Executive Officer
Karina M. FedaszInterim Chief Financial Officer

Board

DirectorRole
Andrew OakleyChairman of the Board
Sammy DorfDirector
Sarah RomanoDirector
Thomas MeierDirector

Events

QuarterResultsShare move
Q3 2026Nov 16, 2026−6.5%
Q2 2026Aug 13, 2026−9.1%
Q1 2026May 11, 2026+7.4%
Q4 2025Mar 12, 2026−13.1%
Q3 2025Nov 28, 2025+13.3%
Q2 2025Aug 29, 2025−2.3%
Q1 2025May 30, 20250.0%
Q4 2024Mar 6, 2025+0.9%
Q3 2024Nov 7, 2024+0.8%
Q2 2024Aug 12, 2024−4.3%
All 20 quarters
QuarterResultsShare move
Q1 2024May 20, 2024 · After close−15.7%
Q4 2023Mar 7, 2024−6.7%
Q3 2023Nov 17, 2023 · After close−2.6%
Q2 2023Aug 14, 20230.0%
Q1 2023May 12, 2023 · After close0.0%
Q4 2022Mar 9, 20230.0%
Q3 2022Nov 10, 20220.0%
Q2 2022Aug 15, 20220.0%
Q1 2022May 13, 20220.0%
Q4 2021Feb 23, 20220.0%

Open Events

IPO

Went public as Blue Water Vaccines Inc. Priced at US$9.00 a share. Final prospectus filed on Feb 23, 2022.

Price
US$9.00 a share
Shares offered
2,222,222 shares of common stock
Offering size
US$20 million
Listing
BWV on the Nasdaq Capital Market
Underwriter
Boustead Securities, LLC
Shares delivered
On or about Feb 23, 2022

Steps

StepWhen
Draft sent to the SEC in confidenceAug 23, 2021
Filed publiclyOct 8, 2021
Amended 6 timesNewest Feb 8, 2022
Declared effective by the SECFeb 11, 2022
Shares registered with an exchangeFeb 17, 2022
Final prospectus, with the priceFeb 23, 2022

Open IPO · From the cover of the final prospectus (424B4) filed Feb 23, 2022

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue815.4K2.52M58.5K000
Cost of revenue182.5K1.47M1.19M6.75K4.89K3.06K573
Gross profit632.9K1.06M-1.13M-6.75K-4.89K-3.06K-573
Research and development66.1K154.4K1.95M4.13M1.33M524.9K60.2K
Selling, general and administrative7.04M11.2M14.8M9.35M2.09M1.10M
Operating income-17.9M-56.5M-36.0M-13.5M-3.42M-1.62M-880.2K
Depreciation and amortization15.2K731.3K43.9K6.75K4.89K3.06K573
EBITDA-17.8M-55.8M-36.0M-13.5M-3.41M-1.62M-879.7K
Interest expense751.0K873.4K671.6K0
Income before tax-14.0M-59.7M-37.4M-13.4M-3.42M-1.60M-821.9K
Income tax525-1.05M-12.6K3.16T675.7B-203.2K-3
Net income-14.0M-58.7M-37.4M-13.4M-3.42M-1.60M-821.9K
Earnings per share, basic-16.56-1,823.39-87.45-1.10-1.26-140.65-72.28
Earnings per share, diluted-16.56-1,823.39-87.45-1.10-1.26

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents5.22M646.5K4.55M25.8M1.93M4.31M6.05M
Receivables296.9K25.7K149.7K35.9K152.5K44.8K8.33K
Inventory150.0K64.1K364.1K0757.6K-35.0K
Current assets6.07M950.3K5.84M26.3M3.07M4.60M6.06M
Property, plant and equipment37.1K62.9K60.7K14.1K11.5K
Goodwill18.5M18.5M55.7M0
Total assets24.9M28.2M87.5M26.3M3.08M4.81M6.08M
Accounts payable1.76M3.79M5.30M1.50M582.6K68.7K18.4K
Current liabilities9.14M18.3M17.2M3.92M1.64M68.7K75.8K
Long-term debt118.9K
Total debt48.8K9.45M9.89M
Total liabilities9.16M18.6M21.9M3.92M1.64M78.3K82.6K
Shareholders' equity15.8M8.54M-5.60M22.4M1.45M4.73M6.00M
Shares outstanding31.2K138.3K558.1K15.3M3.20M11.4K11.4K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-9.68M-10.5M-13.6M-8.68M-2.04M-1.73M-825.1K
Capital spending0-28.5K-3.30K-9.34K-1.92K-11.8K-4.50K
Free cash flow-9.68M-10.5M-13.6M-8.68M-2.05M-1.74M-829.6K
Cash from investing-28.5K-8.65M-32.7K-1.92K-11.8K-4.50K
Cash from financing14.5M6.74M1.04M32.5M-334.2K06.88M
Dividends paid-409.5K-206.4K
Share buybacks-1.71M-718-59.0K-566.8K0
Change in cash4.57M-3.91M-21.2M23.8M-2.38M-1.74M6.05M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 16, 2026Quarterly reportSEC
8-K · Current reportNov 12, 2026Meeting outcomeSEC
8-K · Current reportNov 9, 2026Current reportSEC
425Nov 5, 2026Other filingsSEC
8-K · Current reportNov 5, 2026Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 5, 2026Big-stake noticeSEC
425Oct 27, 2026Other filingsSEC
8-K · Current reportOct 26, 2026Current reportSEC
DEFA14A · Additional proxy materialOct 23, 2026Meeting noticeSEC
8-K · Current reportOct 23, 2026Current reportSEC
Show 200 filings
FilingDateTypeFiled with
425Oct 23, 2026Other filingsSEC
ARS · Annual report to shareholdersOct 16, 2026Annual reportSEC
DEF 14A · Proxy statementOct 7, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementSep 17, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 14, 2026Meeting noticeSEC
8-K · Current reportSep 14, 2026Material contractSEC
425Sep 14, 2026Other filingsSEC
424B3 · ProspectusSep 8, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 4, 2026Other filingsSEC
425Sep 3, 2026Other filingsSEC
S-1/A · Registration statement, amendedAug 31, 2026Offer documentSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
S-1 · Registration statementAug 12, 2026Offer documentSEC
425Aug 6, 2026Other filingsSEC
8-K · Current reportJul 29, 2026Material contractSEC
SCHEDULE 13G · Big-stake noticeJul 27, 2026Big-stake noticeSEC
425Jul 7, 2026Other filingsSEC
425Jun 24, 2026Other filingsSEC
424B3 · ProspectusJun 17, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveJun 17, 2026Other filingsSEC
CORRESP · Letter to the SECJun 15, 2026Other filingsSEC
UPLOAD · Letter from the SECJun 12, 2026Other filingsSEC
S-1 · Registration statementJun 8, 2026Offer documentSEC
8-K · Current reportMay 19, 2026Current reportSEC
8-K · Current reportMay 13, 2026Current reportSEC
10-Q · Quarterly reportMay 13, 2026Quarterly reportSEC
EFFECT · Notice that a registration is effectiveMay 12, 2026Other filingsSEC
424B3 · ProspectusMay 11, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 8, 2026Other filingsSEC
S-1/A · Registration statement, amendedMay 7, 2026Offer documentSEC
CORRESP · Letter to the SECMay 7, 2026Other filingsSEC
POS AM · Amendment to an effective registrationMay 6, 2026Offer documentSEC
UPLOAD · Letter from the SECMay 5, 2026Other filingsSEC
8-K · Current reportMay 4, 2026Meeting outcomeSEC
S-1 · Registration statementApr 28, 2026Offer documentSEC
8-K · Current reportApr 24, 2026Management or board changeSEC
4 · Change in ownershipApr 22, 2026Insider tradeSEC
4 · Change in ownershipApr 21, 2026Insider tradeSEC
4 · Change in ownershipApr 16, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 16, 2026Insider tradeSEC
425Apr 9, 2026Other filingsSEC
425Apr 2, 2026Other filingsSEC
425Mar 31, 2026Other filingsSEC
DEF 14A · Proxy statementMar 30, 2026Meeting noticeSEC
3 · Initial statement of ownershipMar 27, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 27, 2026Insider tradeSEC
8-K · Current reportMar 26, 2026Current reportSEC
425Mar 25, 2026Other filingsSEC
8-K/A · Current report, amendedMar 25, 2026Management or board changeSEC
8-K · Current reportMar 24, 2026Management or board changeSEC
PRE 14A · Preliminary proxy statementMar 18, 2026Meeting noticeSEC
10-K · Annual reportMar 13, 2026Annual reportSEC
425Feb 12, 2026Other filingsSEC
8-K · Current reportFeb 12, 2026Material contractSEC
8-K · Current reportFeb 9, 2026Meeting outcomeSEC
DEF 14A · Proxy statementJan 2, 2026Meeting noticeSEC
EFFECT · Notice that a registration is effectiveDec 29, 2025Other filingsSEC
424B3 · ProspectusDec 23, 2025Offer documentSEC
CORRESP · Letter to the SECDec 22, 2025Other filingsSEC
PRE 14A · Preliminary proxy statementDec 22, 2025Meeting noticeSEC
S-1/A · Registration statement, amendedDec 19, 2025Offer documentSEC
3 · Initial statement of ownershipDec 12, 2025Insider tradeSEC
8-K · Current reportDec 10, 2025Management or board changeSEC
8-K · Current reportDec 10, 2025Material contractSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
424B3 · ProspectusNov 10, 2025Offer documentSEC
DEF 14A · Proxy statementNov 10, 2025Meeting noticeSEC
S-1 · Registration statementNov 4, 2025Offer documentSEC
8-K · Current reportOct 29, 2025Current reportSEC
PRE 14A · Preliminary proxy statementOct 28, 2025Meeting noticeSEC
S-1 · Registration statementOct 15, 2025Offer documentSEC
DOct 7, 2025Other filingsSEC
8-K · Current reportOct 3, 2025Material contractSEC
8-K · Current reportSep 26, 2025Material contractSEC
8-K · Current reportSep 22, 2025Material contractSEC
8-K · Current reportSep 4, 2025Material contractSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 12, 2025Material contractSEC
4 · Change in ownershipJul 16, 2025Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJul 16, 2025Big-stake noticeSEC
8-K · Current reportJul 16, 2025Material contractSEC
8-K · Current reportJun 16, 2025Current reportSEC
10-Q · Quarterly reportJun 12, 2025Quarterly reportSEC
8-K · Current reportJun 11, 2025Material contractSEC
8-K · Current reportJun 5, 2025Meeting outcomeSEC
10-K · Annual reportJun 2, 2025Annual reportSEC
8-K · Current reportMay 22, 2025Material contractSEC
UPLOAD · Letter from the SECMay 2, 2025Other filingsSEC
8-K · Current reportApr 30, 2025Current reportSEC
DEF 14A · Proxy statementApr 29, 2025Meeting noticeSEC
PRER14AApr 28, 2025Other filingsSEC
PRE 14A · Preliminary proxy statementApr 18, 2025Meeting noticeSEC
8-K · Current reportApr 18, 2025Current reportSEC
8-K · Current reportApr 8, 2025Current reportSEC
8-K · Current reportApr 3, 2025Management or board changeSEC
NT 10-K · Late filing noticeApr 1, 2025Explanation requestSEC
4 · Change in ownershipMar 25, 2025Insider tradeSEC
8-K · Current reportMar 24, 2025Current reportSEC
8-K · Current reportMar 19, 2025Current reportSEC
3 · Initial statement of ownershipMar 7, 2025Insider tradeSEC
8-K · Current reportFeb 28, 2025Material contractSEC
8-K · Current reportFeb 18, 2025Material contractSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2025Big-stake noticeSEC
424B3 · ProspectusFeb 12, 2025Offer documentSEC
EFFECT · Notice that a registration is effectiveFeb 12, 2025Other filingsSEC
CORRESP · Letter to the SECFeb 10, 2025Other filingsSEC
S-1/A · Registration statement, amendedFeb 7, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 7, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECFeb 3, 2025Other filingsSEC
S-1 · Registration statementJan 27, 2025Offer documentSEC
8-K · Current reportJan 24, 2025Current reportSEC
8-K · Current reportJan 22, 2025Current reportSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
424B3 · ProspectusDec 17, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveDec 13, 2024Other filingsSEC
8-K · Current reportDec 12, 2024Current reportSEC
CORRESP · Letter to the SECDec 11, 2024Other filingsSEC
S-1/A · Registration statement, amendedDec 11, 2024Offer documentSEC
S-8 · Registration statement for employee plansDec 11, 2024Offer documentSEC
S-1/A · Registration statement, amendedDec 10, 2024Offer documentSEC
10-Q · Quarterly reportDec 9, 2024Quarterly reportSEC
8-K · Current reportDec 3, 2024Material contractSEC
NT 10-Q · Late filing noticeNov 15, 2024Explanation requestSEC
424B4 · ProspectusNov 15, 2024Offer documentSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveNov 13, 2024Other filingsSEC
CORRESP · Letter to the SECNov 12, 2024Other filingsSEC
S-1/A · Registration statement, amendedNov 12, 2024Offer documentSEC
CORRESP · Letter to the SECNov 12, 2024Other filingsSEC
CORRESP · Letter to the SECNov 12, 2024Other filingsSEC
CORRESP · Letter to the SECNov 12, 2024Other filingsSEC
S-1/A · Registration statement, amendedNov 12, 2024Offer documentSEC
UPLOAD · Letter from the SECNov 7, 2024Other filingsSEC
UPLOAD · Letter from the SECNov 7, 2024Other filingsSEC
S-1 · Registration statementNov 1, 2024Offer documentSEC
S-1 · Registration statementNov 1, 2024Offer documentSEC
3/A · Initial statement of ownership, amendedNov 1, 2024Insider tradeSEC
DEF 14COct 31, 2024Meeting noticeSEC
8-K · Current reportOct 21, 2024Current reportSEC
PRE 14COct 18, 2024Meeting noticeSEC
DOct 17, 2024Other filingsSEC
8-K/A · Current report, amendedOct 9, 2024FinancingSEC
8-K · Current reportOct 3, 2024Material contractSEC
SC 13D · Big-stake noticeOct 1, 2024Big-stake noticeSEC
SC 13D · Big-stake noticeOct 1, 2024Big-stake noticeSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
4 · Change in ownershipSep 30, 2024Insider tradeSEC
SCHEDULE 13G · Big-stake noticeSep 27, 2024Big-stake noticeSEC
3 · Initial statement of ownershipSep 26, 2024Insider tradeSEC
SC 13D · Big-stake noticeSep 26, 2024Big-stake noticeSEC
4 · Change in ownershipSep 26, 2024Insider tradeSEC
4 · Change in ownershipSep 26, 2024Insider tradeSEC
SC 13G · Big-stake noticeSep 26, 2024Big-stake noticeSEC
8-K · Current reportSep 24, 2024FinancingSEC
8-K · Current reportSep 20, 2024Material contractSEC
8-K · Current reportSep 20, 2024Current reportSEC
8-K · Current reportSep 10, 2024Meeting outcomeSEC
8-K · Current reportSep 4, 2024Current reportSEC
DEFA14A · Additional proxy materialSep 3, 2024Meeting noticeSEC
8-K · Current reportSep 3, 2024Current reportSEC
10-Q · Quarterly reportAug 29, 2024Quarterly reportSEC
NT 10-Q · Late filing noticeAug 14, 2024Explanation requestSEC
8-K · Current reportAug 7, 2024Current reportSEC
DEF 14A · Proxy statementAug 1, 2024Meeting noticeSEC
PRER14AJul 22, 2024Other filingsSEC
8-K · Current reportJul 15, 2024Current reportSEC
8-K · Current reportJul 11, 2024Material contractSEC
424B4 · ProspectusJul 3, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveJul 2, 2024Other filingsSEC
CORRESP · Letter to the SECJun 28, 2024Other filingsSEC
S-1/A · Registration statement, amendedJun 24, 2024Offer documentSEC
CORRESP · Letter to the SECJun 24, 2024Other filingsSEC
PRER14AJun 24, 2024Other filingsSEC
3 · Initial statement of ownershipJun 20, 2024Insider tradeSEC
8-K/A · Current report, amendedJun 14, 2024Management or board changeSEC
UPLOAD · Letter from the SECJun 14, 2024Other filingsSEC
CORRESP · Letter to the SECJun 13, 2024Other filingsSEC
8-K · Current reportJun 13, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedJun 10, 2024Big-stake noticeSEC
S-1/A · Registration statement, amendedJun 4, 2024Offer documentSEC

This page holds 200 of 401 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Onconetix, Inc.’s releases · as of Nov 10, 2026

Common shares
820,611
Fully diluted
820,611

Fully diluted

LineSharesAs of
Common shares820,611Nov 10, 2026

Share count over time

CountShares
Nov 10, 2026820,611
Oct 26, 2026
May 19, 2026

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Virtu Financial LLC78,6339.6%US$62,000Sep 30, 2026
Susquehanna27,6903.4%US$21,662Sep 30, 2026
Geode Capital22,6422.8%US$17,712Sep 30, 2026
Jane Street15,4701.9%US$12,103Sep 30, 2026
UBS15,4501.9%US$12,082Sep 30, 2026
StoneX Group Inc.15,4091.9%US$12,053Sep 30, 2026
Stratos Wealth Partners, LTD.12,6651.5%US$9,908Sep 30, 2026
SBI Securities Co., Ltd.3130.04%US$245Sep 30, 2026
Robinhood Markets, Inc.1060.01%US$84Sep 30, 2026
Barclays1<0.01%US$1Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund1,1720.14%US$1,406May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Hrt Financial LP
10% owner
Sale49,710USD 0.69US$34,300Apr 21, 2026
Hrt Financial LP
10% owner
Sale94,462USD 0.75US$70,847Apr 20, 2026
Hrt Financial LP
10% owner
Buy34,636USD 0.73US$25,284Apr 17, 2026
Hrt Financial LP
10% owner
Sale53,867USD 0.73US$39,323Apr 16, 2026
Hrt Financial LP
10% owner
Buy92,554USD 0.76US$70,341Apr 15, 2026
Hrt Financial LP
10% owner
Buy74,350USD 0.77US$57,250Apr 14, 2026

Big stakes

StakeStakeSharesDateFiling
Ralph Schiess4.63%673KJan 2, 2025Schedule 13D
Christian Bruhlmann4.20%611KJan 2, 2025Schedule 13D

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Sapirstein
Other companies: INmune Bio Inc. (Director · Since at least Sep 8, 2026); Cocrystal Pharma, Inc. (Chief Executive Officer · Since at least Jun 3, 2026); ZyVersa Therapeutics, Inc. (Director · Since at least Jan 5, 2023); Blue Water Acquisition Corp (Director · Dec 15, 2020 – Dec 15, 2020 · Past); Marizyme, Inc. (Interim CEO, Director · Sep 10, 2020 – Mar 5, 2021 · Past); GridAI Technologies Corp. (Chairman and CEO, Director · Oct 8, 2019 – Jul 2, 2024 · Past); Lunai Bioworks Inc. (Director · Mar 6, 2018 – Jun 25, 2024 · Past); Hepion Pharmaceuticals, Inc. (Chief Executive Officer, Director · Jan 3, 2018 – Jan 3, 2018 · Past); RespireRx Pharmaceuticals Inc (Director · Dec 9, 2017 – Dec 9, 2017 · Past)
Director · Feb 23, 2022 – Sep 26, 2024 · Past
Bruce Harmon
Other companies: Idaho Copper Corporation (Chief Financial Officer · Since at least Jul 28, 2026); Marizyme, Inc. (CFO · Sep 1, 2020 – Oct 22, 2020 · Past); Green Innovations Ltd (Director · May 16, 2013 – Dec 31, 2014 · Past)
Chief Financial Officer · Oct 4, 2023 – Oct 4, 2023 · Past
Joseph Hernandez
Other companies: Blue Water Acquisition Corp. IV (Chief Executive Officer, Director · Since at least Mar 19, 2026); Blue Water Acquisition Corp. III (Chief Executive Officer, Director · Since at least Jun 9, 2025); Clarus Therapeutics Holdings Inc (Director · Apr 25, 2022 – Jun 7, 2022 · Past)
CEO, Director · May 4, 2022 – May 9, 2023 · Past
Kimberly M Murphy
Other companies: Clarus Therapeutics Holdings Inc (Director · Dec 12, 2021 – Jun 7, 2022 · Past); Blue Water Acquisition Corp (Director · Dec 14, 2020 – Dec 14, 2020 · Past); Oragenics Inc. (Director · May 1, 2020 – Sep 19, 2024 · Past)
Director · Feb 17, 2022 – May 4, 2022 · Past
Sarah Romano
Other companies: SS Innovations International Inc. (CFO · Since at least Jul 15, 2026); Vicarious Surgical, Inc. (Chief Financial Officer · Since at least Apr 1, 2025); GridAI Technologies Corp. (Chief Financial Officer · Jan 3, 2023 – Jan 6, 2025 · Past)
Director · Since at least Dec 5, 2025
Allan Shaw
Other companies: CalciMedica, Inc. (Director · Since at least Mar 20, 2023); VIVUS Inc (Director · Oct 15, 2017 – Oct 26, 2018 · Past)
Director · Feb 17, 2022 – Aug 19, 2022 · Past
Vuk Jeremić
Other companies: Skyline Builders Group Holding Limited (Director · Since at least Mar 31, 2026); Aureus Greenway Holdings Inc. (Director · Since at least Sep 9, 2025)
Director · Nov 4, 2022 – May 31, 2023 · Past
Andrew Oakley
Other companies: Tribeca Strategic Acquisition Corp. (Director · Since at least May 28, 2026)
Chairman of the Board · Since at least Feb 24, 2025
David White
Other companies: Realbotix Corp (Chief Executive Officer · Mar 31, 2026 – Nov 4, 2026 · Past)
Chief Executive Officer · Since at least Mar 31, 2026
Karina M. Fedasz
Other companies: IDW Media Holdings, Inc. (CFO, Treasurer & Corporate Sec · Jul 1, 2021 – Jul 1, 2021 · Past)
Interim Chief Financial Officer · Since at least Jun 10, 2024
All 16 people
PersonSeat
Simon Tarsh
Other companies: Lunai Bioworks Inc. (Interim CFO · Mar 11, 2024 – Nov 4, 2024 · Past)
Director · Since at least Aug 22, 2022
Christian BruhlmannChief Strategy Officer · Dec 15, 2023 – Dec 20, 2024 · Past
Neil J CampbellChief Executive Officer, Director · Oct 4, 2023 – Oct 4, 2023 · Past
Ralph SchiessInterim CEO, CSO · Dec 15, 2023 – Dec 20, 2024 · Past
Sammy DorfDirector · Since at least Mar 31, 2026
Thomas MeierDirector · Since at least Feb 6, 2024

Open People

Log in to ask 6ix AI your own questions about Onconetix, Inc.